Azenta Inc (AZTA)
44.92
+3.70
(+8.98%)
USD |
NASDAQ |
Nov 04, 16:00
44.86
-0.06
(-0.13%)
After-Hours: 20:00
Azenta Revenue (Quarterly): 172.81M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 172.81M |
| March 31, 2024 | 159.13M |
| December 31, 2023 | 154.32M |
| September 30, 2023 | 172.36M |
| June 30, 2023 | 165.95M |
| March 31, 2023 | 148.40M |
| December 31, 2022 | 178.37M |
| September 30, 2022 | 137.57M |
| June 30, 2022 | 132.74M |
| March 31, 2022 | 145.54M |
| December 31, 2021 | 139.65M |
| September 30, 2021 | 136.94M |
| June 30, 2021 | 129.09M |
| March 31, 2021 | 129.54M |
| December 31, 2020 | 118.14M |
| September 30, 2020 | -262.54M |
| June 30, 2020 | 220.35M |
| March 31, 2020 | 220.23M |
| December 31, 2019 | 210.50M |
| September 30, 2019 | -247.46M |
| June 30, 2019 | 203.88M |
| March 31, 2019 | 198.39M |
| December 31, 2018 | 179.37M |
| September 30, 2018 | 159.65M |
| June 30, 2018 | 172.36M |
| Date | Value |
|---|---|
| March 31, 2018 | 156.95M |
| December 31, 2017 | 142.60M |
| September 30, 2017 | 16.49M |
| June 30, 2017 | 181.72M |
| March 31, 2017 | 169.33M |
| December 31, 2016 | 159.96M |
| September 30, 2016 | 31.24M |
| June 30, 2016 | 147.53M |
| March 31, 2016 | 135.28M |
| December 31, 2015 | 119.96M |
| September 30, 2015 | 145.76M |
| June 30, 2015 | 144.89M |
| March 31, 2015 | 139.31M |
| December 31, 2014 | 122.74M |
| September 30, 2014 | 122.52M |
| June 30, 2014 | 117.36M |
| March 31, 2014 | 125.90M |
| December 31, 2013 | 117.07M |
| September 30, 2013 | 110.68M |
| June 30, 2013 | 110.77M |
| March 31, 2013 | 109.48M |
| December 31, 2012 | 98.02M |
| September 30, 2012 | 88.98M |
| June 30, 2012 | 140.44M |
| March 31, 2012 | 139.34M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-262.54M
Minimum
Sep 2020
220.35M
Maximum
Jun 2020
137.32M
Average
148.40M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Bruker Corp | 800.70M |
| Harvard Bioscience Inc | 23.10M |
| Bionano Genomics Inc | 7.771M |
| Akoya Biosciences Inc | 23.16M |
| Singular Genomics Systems Inc | 0.737M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.582M |
| Total Expenses (Quarterly) | 185.50M |
| EPS Diluted (Quarterly) | -0.12 |
| Enterprise Value | 1.420B |
| Gross Profit Margin (Quarterly) | 39.96% |
| Profit Margin (Quarterly) | -3.81% |
| Earnings Yield | -6.26% |
| Normalized Earnings Yield | -1.188 |